Breast Cancer Breakthrough: Past Drugs
Posted on: Thursday, 14 April 2005, 06:00 CDT
The hormonal drug Tamoxifen has been the gold standard in breast cancer treatment since the 70s. It has cut the death rate from breast cancer by reducing the recurrence of the disease in women who have had surgery and/or radiotherapy by 50 per cent. However, side effects include an increased risk of blood clots, stroke and endometrial cancer .
The development of a new class of drugs called aromatase inhibitors in the past five years has persuaded many doctors they found a breakthrough. Results from a trial of the first drug, called anastrozoleshowed it cut the recurrence of breast cancer in women who had already been treated for the disease by 76 per cent, with a lot less side-effects.
Source: Independent, The; London (UK)
Related Articles
- Video from Medialink and P&G: Procter & Gamble Partners with National Breast Cancer Foundation, Inc. to GIVE HOPE to Millions of Women Across the Country
- News from Medialink and P&G: Procter & Gamble Partners with National Breast Cancer Foundation, Inc. to GIVE HOPE to Millions of Women Across the Country
- Preclinical Data Show Alfacell's ONCONASE(R) Inhibits Tumor Growth of Non-Small Cell Lung Cancer, Breast Cancer Cells
- St. Louis Cancer & Breast Institute Physician Says Hormone Replacement Therapy Does Indeed Create Breast Cancer Risk
- Breast and Prostate Cancer Feared Most
- HEALTH: 10 FACTS YOU SHOULD KNOW ABOUT BEATING BREAST CANCER ; Breast Cancer is Estimated to Affect One in Nine Women in Britain. Luckily, There Have Been Huge Developments in Treatments Available Heres a Look at What the Future Holds for the Fight Again
- MR Spectroscopy Helps Identify Cancerous Breast Tumors
- A New Insight into Breast Cancer: Breast Density is Directly Related to Breast Cancer
- I'D Had Cancer, a Breast Lump Removed and Was Getting on for 40
- Report: Prostate Cancer, Breast Cancer Leading Newly Diagnosed Cancers
 |
 |
User Comments (0)
RSS Feeds